Abstract Substance use among people living with HIV is high, and screening, brief intervention, and referral to treatment (SBIRT) is an evidence-based approach to addressing the issue. We examined whether patients would participate in a technology-based SBIRT program in an urban HIV clinic. An SBIRT intervention was programmed into the clinic's web-based patient portal linked to their personal health record. We examined: demographic, health, HIV, and substance use characteristics of participants who completed the web-based intervention compared to those who did not. Fewer than half of the 96 participants assigned to the web-based SBIRT completed it (n = 39; 41 %). Participants who completed the webbased intervention had significantly higher amphetamine SSIS scores than those who did not complete the intervention. Participants whose substance use is more harmful may be more motivated to seek help from a variety of sources. In addition, it is important that technology-based approaches to behavioral interventions in clinics take into consideration feasibility, client knowledge, and comfort using technology.
Introduction
Alcohol and other drug use are common among people living with HIV (PLHIV) [1] and are recognized co-factors of HIV transmission [2, 3] . More serious substance use disorders (SUDs) among PLHIV are associated with high rates of HIV transmission risk behaviors [4] and low antiretroviral therapy (ART) adherence [5] . Alcohol use is the most prevalent risk factor for poor HIV medication adherence and is associated with lower CD4 counts [6] . Methamphetamine and other amphetamine-type stimulant use is also a critical factor in HIV transmission [4] . Few HIV clinical settings, however, routinely assess patients for unhealthy substance use [7] .
Screening, brief intervention, and referral to treatment (SBIRT) is a public health approach to the delivery of early intervention and treatment services for persons with or at risk of developing alcohol and drug use disorders. Screening uses evidence-based tools to quickly identify patients with unhealthy alcohol or drug use and assess them for substance abuse and dependence. Brief Interventions with at-risk patients are short, patient-centered conversations to provide feedback, assess readiness for change, and enhance patient motivation. Referral to Treatment refers to action planning that supports patients ready to make a change. Action plans may range from self-management strategies (e.g., cutting down), office-based medicationassisted-treatment (e.g., buprenorphine, naltrexone), or referral to specialty care (e.g., detoxification, outpatient or residential treatment) [8] . Brief intervention (BI) approaches are typically delivered on site, and individuals with more severe substance use problems are also given referrals to specialized treatment. BI for patients with risky drinking has strong support in the alcohol literature [9, 10] and some promising effects have been observed with respect to other forms of substance use [11] [12] [13] [14] . Although the evidence base supporting BI for substance use is still developing, studies have found that BIs can be effective in reducing heroin and cocaine use [12] [13] [14] as well as amphetamine use [14] .
In the field of substance use identification, treatment and support, empirical evidence suggests that information and communication technologies (including interactive web and mobile technology tools) may increase patient access to evidence-based behavioral treatments and interventions [15] . In addition, electronic personal health records (ePHR) have demonstrated potential to improve quality of health care and patient outcomes associated with managing a chronic illness [16] . Fostering patient use of technology for self-management of chronic diseases also could result in decreased demand on clinicians in primary care environments. Several studies have shown the acceptability of utilizing ePHRs in HIV primary care clinics [17, 18] . In these studies, young Caucasian men found the ePHR to be a useful tool in managing their HIV care, but the studies were not able to enroll a more diverse racial or gender sample. Investigators of another study found that substance use itself was not a barrier to completing online health related surveys through an ePHR in an urban HIV clinic sample [17] . An online web-based SBIRT intervention could be a feasible method for addressing substance use in an HIV primary care clinic. Even if such an intervention demonstrates only modest efficacy for reducing unhealthy alcohol and drug use, the potential to reach a broader population of high-risk patients through web-based interactions could translate to a substantial public health impact [19] . SBIRT may help health care providers identify and help those with, or at risk of, substance-related harms. However, the most feasible modality for delivering SBIRT to safety-net patients in a busy, urban HIV primary care clinic is unknown. Internet-based information and communication technologies have the capacity to increase access to behavioral interventions and may provide a timesaving and innovative mode of delivery. As part of a larger trial, we explored the differences between those who completed versus those who did not complete the intervention, among those assigned to web-based SBIRT.
Methods
The analysis presented here is part of a larger two-arm parallel-group randomized controlled trial that followed participants over 6 months (ClinicalTrials.gov study number NCT01300806) to assess standardized SBIRT for unhealthy substance use. The parent study aimed to determine the feasibility of a computer-administered web-based SBIRT intervention compared to a clinician-administered SBIRT encounter in an HIV primary care clinic with high baseline rates of substance use.
Participants were recruited from the waiting room of San Francisco General Hospital's Positive Health Program (PHP) clinic, which provides primary medical care to more than 2500 PLHIV with 30,000 visits per year. Trained recruiters posted study flyers during primary care clinic hours and obtained contact information from patients expressing interest in participation. In addition, clinic providers mentioned the study to their patients. Interested patients were screened for eligibility and enrolled if appropriate. Study eligibility criteria included: 18 years of age or older; confirmed HIV-positive serostatus; ability to provide informed consent and to be followed over a 6-month period; receiving HIV care at the clinic; and ability to speak English or Spanish. All research and consent materials were available in both languages. Those who were interested and eligible provided written informed consent. Approximately 88 % of people who contacted the study team eventually enrolled. All study protocols were reviewed and approved by the University of California, San Francisco (UCSF) Institutional Review Board and the clinical site. Participants received $35 for completing the study visit. Intervention participation was not reimbursed differentially.
Data Collection
Upon enrolling in the study, each participant completed a self-administered survey booklet of various instruments. The instruments used in the current analysis include the following:
Demographics and Health
This instrument included questions about demographics, including: age, gender, race, education, employment status, income, health insurance, and whether they had children. HIV-related health questions included: year of HIV diagnosis; AIDS diagnosis; self-reported CD4 count and viral load; whether taking ARVs; and three single-item measures of self-reported physical condition, psychological condition, and social support [20] [21] [22] .
Adherence
Using the Adult AIDS Clinical Trials Group (AACTG) Medication Adherence 30-day Visual Analog Scale (VAS), participants were asked to estimate how often they took their medications as prescribed in the past 30 days, on a scale ranging from 0 to 100 % [23] . VAS measures of past 30-day adherence have been found to correlate with other objective measures of adherence as well as viral load [24] .
Depression
The Center for Epidemiology Studies Depression Scale (CES-D) is a 20-item Likert-type scale that measures the level of depressive symptoms experienced over the past week [25] . The total score ranges from 0 to 60, with a higher score indicating more depressive symptoms. We analyzed the CES-D as a continuous measure [25] . Chronbach's alpha was 0.90 for both the full sample and for those participants assigned to the computer-based SBIRT intervention.
Engagement with Healthcare Provider
This was assessed with a 13-item scale where participants were asked to rate their interactions with health care providers on a four-point scale with 1 = always true and 4 = never. Responses are summed to create a total score, with a possible range of 1-52. A low score indicates greater provider engagement. Cronbach's alpha reliability estimate was 0.96 [26] .
Substance Use
Alcohol, tobacco and other drug use was assessed with the World Health Organization's Alcohol, Smoking and Substance Involvement Screening Test (ASSIST). The ASSIST is an internationally validated set of eight questions, covering ten substances [27] . The ASSIST demonstrates excellent concurrent, construct, predictive and discriminative validity and can adequately screen for low, moderate and high risk substance use. For each substance, the ASSIST assesses frequency of use, cravings, impact of use on key life domains, expressed concern from others, and failed quit attempts. The responses to these items are summed for each substance category (e.g. tobacco, amphetamines) to provide a continuous Specific Substance Involvement Score (SSIS) ranging from 0-39 (0-31 for tobacco). Using validated cut points for the SSIS, the ASSIST indexes low risk (0-3, or 0-10 for alcohol), moderate risk (4-26, or 11-26 for alcohol), or high risk (27?) for the presence of disordered patterns of use for each substance assessed.
The SBIRT Intervention
Following baseline data collection, participants in the parent study were randomized via a blinded, computerized randomization program into two groups, a web-based or a clinician-administered intervention. Only data from the 96 patients who were assigned to the web-based intervention are included in this analysis.
The 96 participants were assigned to participate in an interactive, self-administered substance use screening and brief intervention (SBI) that was programmed and embedded into myHERO, a patient portal that is linked with the clinic's electronic medical record. A patient portal is a secure online website that gives patients convenient 24-h access to personal health information from anywhere with an internet connection [28] . Using a secure username and password, patients can view health information linked with the clinic's electronic medical record. MyHERO was available in English and Spanish and patients could access the system from any internet-linked computer, including free computers at city libraries and hospitals. Participants assigned to the web-based arm also could complete the SBI task on one of three clinic computer stations located in the waiting room. If requested by the participant, study staff assisted participants in setting up electronic mail accounts and guided them through how to access the clinic's webbased patient portal in order to access the ePHR, usually spending 30-60 min in this process. Participants also were given the option to complete the SBI from a remote computer within 1 week of study enrollment. We considered the web-based intervention as completed if patients logged on and completed the SBI encounter. The information technology staff supporting the electronic interface validated completion of the intervention.
For the screening component of the web-based SBIRT intervention, participants answered the eight ASSIST screening questions [27] and received feedback in the form of a personalized ''Results'' page, which they could print to save and which showed their estimated level of risk for health and other problems from using each substance they reported. Under each substance, respondents could click on a ''View Risks'' button to view a list of harmful consequences associated with regular use of each substance. Participants were then invited to view ''Advice'' for recommendations based on their SSIS and associated risk category adapted from the ASSIST-linked brief intervention manual, and tailored specifically for PLHIV [11] . Participants at no or low risk of health and other problems from their current pattern of use received positive feedback and links to informational websites that had been preprogrammed into myHERO [29] . Participants at moderate risk received messages of concern, recommendations to seek further evaluation and advice from their primary care provider and social work team, and links to helpful websites, including information about behavioral or medical treatments for specific substances they reported using. For moderate alcohol use risk, they were referred to http:// rethinkingdrinking.niaaa.nih.gov. Moderate-risk participants also received messages reaffirming their autonomy in making any decisions about their substance use and the commitment of the clinic to help them when they are ready to make a change. Participants, who scored at high risk of experiencing severe problems (health, social, financial, legal, relationship) S188 AIDS Behav (2015) 19:S186-S193
as a result of their current pattern of use and were likely to have a diagnosis of substance dependence, received the same information as moderate-risk participants plus additional encouragement to contact the clinic social worker trained in substance use counseling with the goal of referring that patient to specialty addiction treatment.
Analysis
We examined the characteristics of participants assigned to the computer-assisted, web-based SBIRT intervention to identify differences between those who did complete the intervention and those who did not. We compared participants based on demographic, HIV, health, and substance use characteristics (ever use, use in past 3 months, and SSIS scores). Sample characteristics were analyzed using t tests for continuous data and v 2 tests for categorical data. A p value of less than or equal to 0.05 was considered statistically significant. Stata Version 11 software was used for data analysis.
Results
Of the 96 participants who were randomized to the webbased SBIRT intervention, 39 (40.6 %), completed the intervention (Table 1) . (In contrast, 85 % of those assigned to the clinician-based SBIRT intervention completed it. Although not presented here, there were no other differences between the randomized groups). The mean age of participants assigned to the web-based intervention was 45.4 years (SD 8.1). Of these, 64 (66.7 %) were male and 22 (22.9 %) were female; seven were male-to-female transgender individuals; two people identified as additional categories of gender; and one did not report a gender. For the purposes of this analysis, all transgender individuals are classified as women, who therefore make up 30.2 % of the sample. Nearly half of participants (42.7 %) were African American, and two-thirds had a high school equivalent or less education (67.7 %). Most (64.6 %) of the participants reported using tobacco in the past 3 months. The most common currently-used substances were tobacco (64.6 %), alcohol (64.6 %), cocaine (32.3 %), amphetamines (36.5 %) and non-prescribed sedatives (28.1 %).
Among the women who participated in the study, 44.8 % completed the intervention, while only 35.9 % of men did, but this difference was not statistically significant. A number of other differences were noted among groups but also were not statistically significant: those who completed the intervention were on average 2.4 years younger than those who did not; among non-Hispanic White participants, 33.3 % completed the intervention while 66.7 % did not; among Hispanics, 40.0 % completed the webbased SBIRT and 60 % did not; those who completed the intervention had higher self-reported physical condition scores than those who did not (6.8 vs. 6.1); and among those who reported an AIDS diagnosis, 39.5 % completed the intervention.
Participants who completed the web-based intervention had significantly higher amphetamine SSIS scores (mean 14.6 vs. 8.1; t(88) = -2.12, p = 0.04) than those who did not complete the intervention, although both were still within the moderate risk range. SSIS scores for other substances showed no significant differences between webbased intervention completers and non-completers.
Discussion
This study assessed the feasibility of utilizing an ePHR approach to screen for harmful or hazardous substance use using the WHO ASSIST in an urban safety-net HIV primary care clinic population. Fewer than half of the participants randomized to the web-based SBIRT intervention arm completed the intervention. In addition, the two groups-those who did and did not complete the webbased intervention-were statistically similar in all of the measured characteristics except for amphetamine risk score. Participants who completed the web-based intervention had higher SSIS scores for all substances except alcohol, but the only statistically significant difference was among amphetamine users. This finding may indicate that participants whose substance use was more harmful were interested or motivated to seek information or help for their amphetamine use, or were more distressed by their use. Prior research has shown that substance use in and of itself is not necessarily a barrier to the use of technology based approaches [17, [30] [31] [32] . Beyond this, our study found that use of certain substances may actually increase engagement with technology-based health interventions. Substance users who are starting to question their use or who are suffering or distressed by their use may be looking for a convenient and non-judgmental place to start addressing their substance use. Other studies have found that the use of ePHR can improve rates of preventive services in general medical populations [33] , and our findings may indicate a similar role for ePHR in raising concern and offering help to patients in HIV primary care clinics with moderate-tohigh risk methamphetamine use.
While technology-based approaches have demonstrated feasibility in other studies of substance use screening, referral and treatment [34] , the findings from this study indicate that a web-based approach may not be feasible for patients in this urban, safety-net clinic without some modification. Anecdotally, study participants did not indicate that using the computer for the intervention was not acceptable, however the fact that many people assigned to the web-based intervention did not complete it may suggest that using the computer was not acceptable. Because we did not collect data about personal computer access or comfort using the computers as part of our study measures, we cannot determine whether completing the webbased intervention was related to the ''digital divide'', defined as ''the divide between those with access to new technologies and those without'' [35] . We sought to minimize these issues in two ways. First, access to computers and the Internet was facilitated by the availability of three Internet-linked computers in the clinic waiting room where the study was conducted. Study staff also provided a list of places in the nearby area that offered public and free access to computers (e.g. public library). Second, we asked participants whether they felt comfortable using a computer or had experience using the computer. For those participants who reported that they did not, study assistants sat with each participant to walk her/him through setting up electronic mail (email) accounts and logging into their ePHR for the first time during the initial study visit. Our study team did not keep timelogs of how much time was devoted to this, but study documentation indicates that staff spent on average between 30 and 60 min helping participants through this process. The fact that some patients did not have email accounts prior to their study participation suggests they do not have access to newer technologies.
Participants assigned to the web-based screening may also have felt uncomfortable with entering sensitive information into an Internet-linked system, based on concerns about information security. In addition, the positioning of the three computers in the clinic waiting room may have created additional concerns about security and privacy.
Among those patients who did log on to the ePHR, some participants may not have been linked to the intervention because of a programming error, although we are not aware of such an issue. Despite working closely with the programming team that supported myHERO in order to develop the SBI portions of the interactive web-based program, and despite numerous tests with the program, we did not engage in rigorous beta testing, which may have resulted in some remaining programming issues. As with other novel approaches in clinical care, implementation studies that identify training and technical assistance needs by patients are needed [36] .
Age differences may also have affected participation rates. In this study, the mean age of participants was somewhat higher among those who did not complete the intervention (46.3 vs. 43.9 years). While this difference was not statistically significant, it may play a role in who utilizes web-based information and communication technologies for health care related issues, particularly as we come to recognize HIV/AIDS as a disease of accelerated aging. One explanation for this study finding may be that patients who already had email accounts and patient portal access were more likely to complete the web-based intervention. These individuals were younger and may have been using the Internet for a variety of purposes including hook-ups, dating, etc. A recent Pew Report on older adults' usage of the Internet reported that 63 % of older adults would require assistance in using the Internet [37] . Studies in the field of technology-based approaches that target substance use, however, have promise. Technologybased interventions, such as web-based counseling platforms and mobile relapse prevention technology, are more likely to demonstrate impact if they utilize effective informational technology and are developed with the patients who are the intended end-users of the technology, and whose input is taken into account as the technology refinement process is underway [34] . While limited, there are a few studies that indicate that technology-based interventions utilized in conjunction with other evidence-based approaches to substance use demonstrate a positive outcome of treatment for substance use, for example among racially diverse clients of an urban substance abuse treatment provider, and in a population of white injection drug users [15, 38] .
Other limitations of the study included the convenience sampling of participants from the clinic waiting room; thus, our sample may not represent the mix of patients seen at the PHP clinic. The most current patient demographic data for the clinic showed that 84.0 % of participants were male, nearly half (48.3 %) were Caucasian, 24.4 % African American and 22.6 % Latino/a, while our study had more women (30.2 %) and more people of color (68.7 %). To our knowledge, there are few studies that assess the characteristics of patients using ePHR in HIV care. In those studies that have been done, the findings indicate that younger Caucasian populations utilized ePHR. This may have been one of the challenges in our study, because our population was less than 40 % Caucasian.
Finally, we did not collect data on participant experience or satisfaction with the web-based SBIRT intervention. The overall purpose of the parent study was to compare two modalities of SBIRT administration, rather than to look specifically at patient experiences with self-administration of a web-based SBIRT intervention on the computer.
Conclusion
An interactive, web-based SBIRT intervention embedded in the ePHR of patients at an urban, safety net HIV primary care clinic was underutilized. Fewer than half of the participants assigned to the web-based arm completed the intervention, and only amphetamine use differentiated completers versus non-completers. Despite these results, technology-based approaches to addressing substance use in primary care settings are gaining momentum [28, 31] and research on the use of ePHRs as tools for chronic disease management such as HIV is growing. For example, in several studies of patients with diabetes, cardiovascular disease and asthma [16, 36] , patient use of ePHR was related to increased control of biological markers related to disease management. Results from the current study, however, highlight the importance for technology-based approaches to take into consideration patient accessibility, practical knowledge, and personal comfort with using these innovative information and communication technologies. These study findings also highlight a need for caution as we look to technology as a patient care tool in safety-net HIV clinic settings.
